DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

Europe currently dominates the global dental membranes and bone graft substitutes market and is estimated to account for a share of 37.2% in 2024. The region has the highest number of dentists per capita globally. Countries like Germany, the U.K., France, and Italy have a well-established dental industry and healthcare infrastructure. Dental treatments requiring bone grafting or guided tissue regeneration such as dental implants, periodontics and endodontics are widely performed in these countries. The region is also home to several leading players in the dental membranes and bone graft substitutes market, such as Geistlich Pharma and Botiss Biomaterials who have strong brand recognition among dentists. Many European universities have advanced research on dental biomaterials which benefits product development. Governments also support dental research through funding. All these factors have enabled Europe to lead the global market.

The Asia Pacific region is poised to become the fastest growing market for dental membranes and bone graft substitutes. Rapid economic development and growth of the middle-class population have increased accessibility to advanced dental treatments in emerging countries like China, India, and South Korea. Lax intellectual property laws initially benefited the growth of low-cost alternatives. However, awareness about benefits of branded products is increasing among dentists and consumers. At the same time, local manufacturing facilities set up by global companies cater to the large patient volumes. For example, dental bone graft substitutes made from biomaterials such as calcium phosphates are widely used due to their affinity to natural bone. Overall, favorable demand and supply forces are fueling the APAC market growth. The region is sure to play a more prominent role with increased dental spending and new product launches.